Otsuka Pharmaceuticals and Proteus Digital Health released a joint statement on September 10 revealing the Food and Drug Administration (FDA) accepted their new drug application (NDA) for the first sensor-embedded version of Abilify for depression. (Drug Discovery and Davelopment)
Novartis, Qualcomm joint venture backs $6.5M Series A round for Science 37
The joint venture set up by Novartis ($NVS) and Qualcomm ($QCOM) has teamed up with Lux Capital to funnel $6.5 million into Science 37. Los Angeles, CA-based Science 37 will use the cash to step up the expansion of its virtual, tech-enabled model of clinical trial services. (FierceBiotechIT)
Apple: ResearchKit is a pipeline for future diagnostic medical apps
This morning, a number of big name medical institutions launched new studies using apple’s ResearchKit, iPhones and, in at least one case, the Apple Watch. As more ResearchKit study apps become available on Apple’s app store, it appears that many of them are laying the groundwork for future FDA-cleared medical apps. (MobiHealthNews)
New Apple ResearchKit trials focus on epilepsy, autism and skin cancer
Apple launched ResearchKit, its iOS-based platform for clinical research, in March with an initial class of five trials focused on a range of health conditions. Nearly seven months later, the tech giant is welcoming three new trials focused on epilepsy, autism, and melanoma. “ResearchKit was designed to upend how medical research is done.” (Forbes)
Sample Audio News Post
Type your post text here…
Article Link Post
This will be the full content.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam maximus et eros at viverra. Sed placerat ex vitae enim vulputate, ut convallis lorem aliquet. Quisque fringilla fermentum viverra. Vivamus in magna ac nisi mattis pellentesque. Morbi facilisis tellus ut dapibus congue.
Video Post
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam maximus et eros at viverra. Sed placerat ex vitae enim vulputate, ut convallis lorem aliquet. Quisque fringilla fermentum viverra. Vivamus in magna ac nisi mattis pellentesque. Morbi facilisis tellus ut dapibus congue. Curabitur justo tortor, egestas a est eget, cursus maximus Read more
- « Previous Page
- 1
- …
- 44
- 45
- 46